# Efficacy Study of Omalizumab in Cholinergic Urticaria

> **NCT02012387** · PHASE2 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 24 (actual)

## Conditions studied

- Cholinergic Urticaria

## Interventions

- **BIOLOGICAL:** Active
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Open labeled

## Key facts

- **NCT ID:** NCT02012387
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-09
- **Final completion:** 2017-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012387, "Efficacy Study of Omalizumab in Cholinergic Urticaria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02012387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*